基本信息 产品详情 公司简介 推荐产品
网站主页 CDK4, HUMAN, 重组蛋白 (GST) CDK4, Human, 重组蛋白 (GST)
  • CDK4, Human, 重组蛋白 (GST)|TMPY-04548|TargetMol

CDK4, Human, 重组蛋白 (GST)|TMPY-04548|TargetMol

CDK4 Protein, Human, Recombinant (GST)
11100 500μg 起订
上海 更新日期:2026-05-08

TargetMol 中国(陶术生物)

VIP1年
联系人:邵经理
电话:400-821-0310拨打
手机:15002144251 拨打
邮箱:xuexiang.shao@tsbiochem.com

产品详情:

中文名称:
CDK4, Human, 重组蛋白 (GST)
英文名称:
CDK4 Protein, Human, Recombinant (GST)
品牌:
TargetMol
产地:
美国
保存条件:
Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months
纯度规格:
89.00%
产品类别:
抑制剂
种属:
Human
表达系统:
Baculovirus Insect Cells
蛋白长度:
A DNA sequence encoding the human CDK4 (NP_000066.1) (Met 1-Glu 303) was fused with the GST tag at the N-terminus. Predicted N terminal: Met
标签:
N-GST
货号:
T011|TMPY-04548

Product Introduction

Bioactivity

名称CDK4 Protein, Human, Recombinant (GST)
描述CDK4 is a member of the Ser/Thr protein kinase family. It is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of CDK4 is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). CDK4 was shown to be responsible for the phosphorylation of retinoblastoma gene product. CDK4 is the ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. CDK4 has been shown to be mutated in some types of cancer, whilst a chromosomal rearrangement can lead to Cdk6 overexpression in lymphoma, leukemia and melanoma.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
存储条件Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6 months
关键字CMM-3 | CMM 3
PSK-J3;cyclin-dependent kinase 4;CMM3;TargetMol

公司简介


成立日期 (14年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生物化工,化学试剂,生物技术服务

CDK4, Human, 重组蛋白 (GST)相关厂家报价

内容声明
拨打电话 立即询价